Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IPN

Ipsen (IPN)

Ipsen SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:IPN
DateTimeSourceHeadlineSymbolCompany
1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
07/02/202412:00PMGlobeNewswire Inc.IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2024EU:IPNIpsen SA
07/02/202412:00PMGlobeNewswire Inc.IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2024EU:IPNIpsen SA
07/02/20241:00AMGlobeNewswire Inc.Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine tumors based on positive CABINET Phase III trialEU:IPNIpsen SA
07/02/20241:00AMGlobeNewswire Inc.Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine tumors based on positive CABINET Phase III trialEU:IPNIpsen SA
07/02/20241:00AMGlobeNewswire Inc.Ipsen étend sa collaboration et son accord de licence pour le développement de Cabometyx® dans le traitement des tumeurs neuroendocrines avancées sur la base des résultats positifs de l’essai de Phase III CABINETEU:IPNIpsen SA
06/25/202412:00PMGlobeNewswire Inc.IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2024EU:IPNIpsen SA
06/25/202412:00PMGlobeNewswire Inc.IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2024EU:IPNIpsen SA
06/18/202412:00PMGlobeNewswire Inc.IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2024EU:IPNIpsen SA
06/18/202412:00PMGlobeNewswire Inc.IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2024EU:IPNIpsen SA
06/11/202412:00PMGlobeNewswire Inc.IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2024EU:IPNIpsen SA
06/11/202412:00PMGlobeNewswire Inc.IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2024EU:IPNIpsen SA
06/10/20244:54PMGlobeNewswire Inc.Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitisEU:IPNIpsen SA
06/10/20244:54PMGlobeNewswire Inc.Le médicament Iqirvo® d’Ipsen obtient l’approbation de la FDA via une procédure accélérée comme traitement PPAR premier de sa classe thérapeutique pour la cholangite biliaire primitiveEU:IPNIpsen SA
06/10/20244:54PMGlobeNewswire Inc.Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitisEU:IPNIpsen SA
06/07/20241:00AMGlobeNewswire Inc.Ipsen et Marengo Therapeutics annoncent la conclusion d’un second partenariat stratégique afin de faire progresser les actifs « T-Cell Engager » de précision de la plateforme TriSTAR de MarengoEU:IPNIpsen SA
06/07/20241:00AMGlobeNewswire Inc.Ipsen and Marengo Therapeutics announce second strategic partnership to advance precision T cell engagers from Marengo’s Tri-STAR platformEU:IPNIpsen SA
06/07/20241:00AMGlobeNewswire Inc.Ipsen and Marengo Therapeutics announce second strategic partnership to advance precision T cell engagers from Marengo’s Tri-STAR platformEU:IPNIpsen SA
06/06/202412:00PMGlobeNewswire Inc.Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capitalEU:IPNIpsen SA
06/06/202412:00PMGlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
06/06/20248:30AMGlobeNewswire Inc.Ipsen nomme Josep Catllà, en qualité de Vice-Président Exécutif, Chief Corporate Affairs OfficerEU:IPNIpsen SA
06/06/20248:30AMGlobeNewswire Inc.Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer   EU:IPNIpsen SA
06/06/20248:30AMGlobeNewswire Inc.Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer   EU:IPNIpsen SA
06/05/20242:00AMGlobeNewswire Inc.Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis    EU:IPNIpsen SA
06/03/20241:00AMGlobeNewswire Inc.Ipsen initiates a share buy-back program to cover its free employee share-allocation planEU:IPNIpsen SA
06/03/20241:00AMGlobeNewswire Inc.Ipsen lance un programme de rachat d’actions pour couvrir son programme d’attribution d’actions gratuites aux salariésEU:IPNIpsen SA
05/30/202412:15PMGlobeNewswire Inc.Ipsen announces the launch of an employee shareholding planEU:IPNIpsen SA
05/30/202412:15PMGlobeNewswire Inc.Ipsen annonce le lancement d'une opération d’actionnariat salariéEU:IPNIpsen SA
05/28/202412:00PMGlobeNewswire Inc.Assemblée Générale Annuelle d’Ipsen S.A. du 28 mai 2024EU:IPNIpsen SA
05/28/202412:00PMGlobeNewswire Inc.Annual General Meeting of Ipsen S.A. held on 28 May 2024EU:IPNIpsen SA
 Showing the most relevant articles for your search:EU:IPN